IJMS | Free Full-Text | Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges
Lipid-Lowering Therapies: A Review of Current and Future Options
Sites and targets of lipid-lowering therapies. Approved drugs/drug... | Download Scientific Diagram
Table 3 from Cardiovascular risk reduction: the future of cholesterol lowering drugs. | Semantic Scholar
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4 | Journal of the American College of Cardiology